Novavax Covid-19

Drug firm Zydus Cadila on Wednesday announced that its plasmid DNA vaccine to prevent COVID-19 -- ZyCoV-D -- was found to be safe and well tolerated in the phase I clinical trial. The company will now commence phase II clinical trials from…

A Covid-19 vaccine developed by US-based Novavax elicited robust antibody responses and appeared to be safe in a Phase-I human trial, the company has said.No serious adverse events were reported and safety follow-up continues, Novavax said…